• Published 4 Mar 2021

Chemical Development in Pharma 2: A CatSci Virtual Symposium

Following the fantastic success of the first installment, we hosted a follow-up event on the 4th March 2021; Chemical Development in Pharma Part 2: A CatSci Virtual Symposium. This exciting free event consisted of interesting industry speakers who delivered succinct 25-minute presentations on high throughput experimentation in organic synthesis, separation technology and analytical science. #ChemDev2021
  • Events

Last October, CatSci hosted its inaugural symposium, Chemical Development in Pharma: A CatSci Virtual Symposium. Here, we brought together industry experts and young scientists from across the globe to discuss the latest developments in process chemistry.

Following the fantastic success of the first installment, we hosted a follow-up event on the 4th March 2021; Chemical Development in Pharma Part 2: A CatSci Virtual Symposium. This exciting free event consisted of interesting industry speakers who delivered succinct 25-minute presentations on high throughput experimentation in organic synthesis, separation technology and analytical science. At the end of each talk, there was also time for the speakers to answer questions from attendees, and time allocated throughout the afternoon for networking sessions. #ChemDev2021

The event speakers included:

The complete agenda for the symposium can be downloaded here.

Access the symposium’s recordings

#ChemDev2021

Resources & Insights

  • 12 Aug 2026
  • Rob Crook
Don’t Forget Metrics: How Do We Prove Chemistry Is Actually Green?
  • Green Chemistry
  • Thought Leaders
  • 10 Aug 2026
  • Rob Crook
Innovate Following Nature’s Lead: How Would Nature Solve This Problem?
  • Green Chemistry
  • Thought Leaders
  • 12 Jun 2026
  • Joseph Renny, Simon N. G. Tyler
From Undruggable to Inevitable: Fifteen years of drug development — and what comes next 
  • Artificial Intelligence (AI)
  • Process R&D
  • Thought Leaders
  • 27 May 2026
Celebrating 15 Years of CatSci – From Catalysis to Integrated Drug Development Partner  
  • News